hcv
美英
- n.猪瘟病毒
- 网络丙型肝炎病毒(hepatitis C virus)；丙肝病毒；猪瘟病毒(Hog cholera virus)
hcvhcv
丙型肝炎病毒(hepatitis C virus)
丙型肝炎病毒(HCv)感染是一个全球化的健康问题，普通人群平均感染率达到了3%，我国血清流行病学调查 资料显示一般人群H…
丙肝病毒
丙肝病毒（Hcv ）感染与肝细胞肝癌（Hcc ）的关系日益受到重视。丙肝病毒感染后，尤其是已有肝硬变者，发生肝癌的危险 …
猪瘟病毒(Hog cholera virus)
对猪瘟病毒(HCV)强毒感染抗体阳性 (ODajo>~0．5为阳性)猪，活体采取扁桃体，用猪瘟荧光抗抗体(HC FA) 试验检查HCV，对…
丙型肝炎是由丙肝病毒
丙型肝炎是由丙肝病毒（HCV）所引起，是通过输血或血制品、血透…[详细]丙肝医院排名 丙肝转氨酶高 丙肝诊断标准 丙肝怎 …
丙肝抗体
丙肝抗体（Ａ-Hcv）结果 448.3 参考范围是〈1.00阴性，提示：阳性（+）乙肝表面抗体提示阳性，是不是代表有问题啊?这种 …
1
therapy used to suppress HIV replication is often associated with a paradoxical increase in HCV RNA levels, as well as hepatotoxicity.
此外，抗逆转录病毒治疗用于抑制HIV复制通常与HCVRNA反常升高和肝中毒相关。
2
Reviewers' conclusions: There is no firm evidence of efficacy of any medicinal herbs for HCV infection.
结论：目前尚没有充分的证据表明草药治疗丙型肝炎病毒感染是有效的。
3
Objective To understand the ways of the spread on hepatitis C virus (HCV) for the prevention of hepatitis C.
目的了解丙型肝炎病毒（HCV）的传播途径，为预防丙型肝炎提供依据。
4
HCV-796 drug levels increased less than proportionally with increasing dose, and appeared to reach a plateau at the 1000 mg cohort.
药物水平比例地以逐渐增加的剂量增加了得比少，而且似乎在1000毫克步兵大队到达高地。
5
Once the system was established, the group examined whether sera from patients carrying HCV could infect the human fetal hepatocytes.
一旦该系统建立起了，研究小组又检验HCV携带者的血清能否感染人类胎儿肝细胞。
6
The article reviewed the latest progress of the relationship between the efficiency of Interferon antiviral therapy and HCV genotypes.
本文综述了HCV基因型与干扰素抗病毒疗效相关性的研究进展。
7
A great number of HCV specific oral drugs are in the late stage of development; some have been recently registered.
许多丙肝病毒专用口服药物也处于开发后期，有一些药物最近已获得注册。
8
Screening blood used for transfusion can prevent transmission of HBV and HCV.
对输血用血液进行筛查，可预防乙肝病毒和丙肝病毒传播。
9
Study of HCV replication within liver cells, or hepatocytes, has been hampered by a lack of adequate virus culture systems.
有关HCV在肝脏细胞复制繁殖的很多研究，因为缺乏足够的病毒培养体系而被迫停止不能进行下去。
10
The future seems to hold great promise for HCV specific oral drugs that will be more effective and better tolerated.
未来似乎有望产生更有效更耐受的针对丙肝病毒的口服药物。
11
The rate of spontaneous clearance of childhood HCV infection was comparable between transfusional and nontransfusional cases.
在输血引起的和非输血引起的病例中，儿童HCV感染的自发清除率是大致相同的。
12
Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.
联合这些分子标志物能帮助提高器官在HCV-肝细胞癌患者中的分配。
13
The lack of an in vitro viral replication system and the small animal model of HCV infection hampers anti-HCV studies and drug screening.
由于尚未建立HCV体外复制模型和小动物感染模型，限制了抗HCV作用研究和药物筛选工作。
14
Due to above complications, co-infection with HCV and HIV-1 has imposed a critical challenge in the management of these patients.
综上所述，HIV和HCV的共感染为我们治疗这类病人提出了一个巨大的挑战。
15
To investigate further, the researchers studied 1051 HCV patients and found that 35% carried at least one HFE gene mutation.
更进一步，研究者研究了1051名HCV病人并发现35%携带有至少一种HFE基因突变。
16
Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
肝炎病毒（HCV）：作为一种辅助治疗，以加快在药物疗法的护理标准首先病毒载量下降。
17
The results indicated that hepatitis C might be still spreading in the HCV-endemic area now.
本研究的结果显示目前C型肝炎仍在梓官乡传播中。
18
Hepatitis C virus (HCV) is a major factor of non-A non-B hepatitis transmitted mainly through blood products and is a global health problem.
丙型肝炎病毒（HCV）是输血后肝炎的主要致病因子，给人类的健康造成了极大的危害。
19
Liver tropic virus (HCV, HBV) to increase liver damage, especially in the case of infection overlap.
嗜肝病毒感染（HCV、HBV）加重肝脏损伤，尤以重叠感染为甚。
20
This culture system provides a breakthrough in studying HCV replication in non transformed hepatocytes, the natural target of the virus.
该病毒培养系统是非突变肝细胞内HCV复制扩增技术的突破。
21
Prof Robert Thimme: For HCV patients we have two distinct populations which are either co expressing the inhibitor receptor or not.
Thimme教授：丙型肝炎患者存在两种不同的人群，一种共表达抑制性受体，另一种不表达。
22
The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient.
本发明也涉及用于对患者治疗或预防HCV感染的药盒或药包。
23
Our study further explores the potential effect these flavonoids have in preventing HCV reinfection following liver transplantation.
我们的研究是要进一步探索这些黄酮类化合物在预防移植后肝脏再次感染HCV的潜在作用。
24
Interestingly, HCV replication in the T cells was prevented after neutralization of the virus, and by treatment with interferon.
有趣的是，丙型肝炎病毒在T细胞中的复制能被干扰素抑制。
25
Therefore, therapeutic modulation of insulin sensitivity in patients with HCV infection may have clinical relevance.
因此，对HCV感染患者进行胰岛素敏感性的治疗性调整可能会有临床意义。
26
Question 1: For those reasons, had you come to my STD clinic, we would not have tested you for HBV or HCV, even if you requested it.
问题1：由于这些理由，你来咨询你的性病，我们就不会把你当成乙肝或丙肝测试，即使你请求了它。
27
Hepatitis C virus (HCV) infection is the most common chronic blood-borne viral infection in the United States.
丙型肝炎病毒（HCV）感染是最常见的慢性血源性病毒在美国感染。
28
Intravenous injection to HCV, HBV infection than single or overlapping iron absorption increased significantly.
静脉注射者HCV、HBV单项或重叠感染较烫吸明显增高。
29
HCV recombinant immunoblot assay (RIBA) and HCV RNA testing are used to confirm the diagnosis of HCV infection.
使用丙肝病毒重组免疫印迹分析技术和丙肝病毒核糖核酸检测对丙肝病毒感染进行确诊。
30
Pathogenesis of HCV-associated MPGN is mediated by glomerular deposition of circulating immune complexes containing HCV and anti-HCV.
丙型肝炎发病机制的相关系膜增生型肾炎是介导的肾小球沉积的循环免疫复合物含有丙型肝炎病毒和抗-HCV。